ROCKVILLE, MD, USA I June 5, 2025 I REGENXBIO Inc. (Nasdaq: RGNX) today announced new positive interim data from the Phase ...

With FDA platform technology designation for its viral vector, SRPT can fast-track other therapies using the same ...

This study provides useful information on the impact of Lamin A/C knockdown on gene expression using RNA-Seq analysis. In addition, the impact of Lamin A/C knockdown on telomere dynamics is explored ...

GRASS VALLEY, CA, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- Sibylline Press is proud to announce that they have acquired The Hour of My Death, by renowned author and poet Marge Piercy.

The global protein expression technology market is expected to be reach USD 3,011.8 million in 2025 and is likely to expand ...

In a breakthrough poised to reshape how the United States tackles tick-borne diseases, Nigerian scientist Kosisochukwu ...

Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...

SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") today announced that the tender offer commenced on March 7, 2025 to acquire all of the outstanding common stock of ...

Amid the global climate crisis, national pavilions have also become key arenas for environmental diplomacy.

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a ...